Reports Quality Evaluation on Acupuncture for Treating Acute Attacks of Migraine_Chinese Journal of Evidence-Based Medicine

Authors：

YANG ChunYan , LIU HuiLin , ZHANG Yuan ,  WANG LinPeng

Department of Acupuncture, Beijing Traditional Chinese Medical Hospital, Capital Medical University, Beijing 100010, China;

Corresponding author：

WANG LinPeng, Email: wlp5558@sina.com.cn

Keywords：

Acupuncture; Migraine; Acute attack; Literature evaluation

DOI：

10.7507/1672-2531.20120059

Video：

Export PDF Favorites Scan Get Citation

Abstract Full text Figures/Tables Video References Cited by

Objective　 To assess the quality of randomized controlled trials (RCTs) on acupuncture for treating acute migraine attacks.
Methods　 With the searching terms of acupuncture and migraine, the Cochrane Controlled Trials Register (CCTR), PubMed, MEDLINE, EMbase, CBM, CMCC, CNKI and VIP were searched. The reports quality of the included trials, including the quality of methodology, diagnostic criteria, inclusion/exclusion criteria, acupuncture/control interventions, outcome measures, observing time, and adverse effects reports, was evaluated.
Results　 A total 23 RCTs involving 2645 patients were included, of which only 3 RCTs were of high quality with Jadad scores equal to or more than 4. At present, only a few high quality trials on treating acute attacks of migraine with acupuncture had been reported at home and abroad. The international recognized diagnostic criteria and common evaluation methods had not been used generally, and the design of control was kind of irrational.
Conclusion　 Based on current clinical reports, acupuncture may be effective in the management of acute migraine attacks, but some relevant proof is still required. The further domestic studies should be designed strictly following the international recommended diagnosis and evaluation criteria of migraine, and rational control methods as well.

Citation： YANG ChunYan,LIU HuiLin,ZHANG Yuan,WANG LinPeng. Reports Quality Evaluation on Acupuncture for Treating Acute Attacks of Migraine. Chinese Journal of Evidence-Based Medicine, 2012, 12(3): 365-370. doi: 10.7507/1672-2531.20120059 Copy

1.	郭述苏. 中国偏头痛流行病学调查. 临床神经病学杂志, 1991, 4(2): 65.
2.	Lipton RB, Bigal ME, Diamond M, et al. Migraine prevalence, disease burden, and the need for preventive therapy. Neurology, 2007, 68(5): 343-349.
3.	Badia X, Magaz S, Gutierrez L, et al. The burden of migraine in Spain: beyond direct costs. Pharmacoeconomics, 2004, 22(9): 591-603.
4.	Wang SJ, Chung CS, Chankrachang S, et al. Migraine disability awareness campaign in Asia: migraine assessment for prophylaxis. Headache, 2008, 48(9): 1356-1365.
5.	Goadsby PJ, Sprenger T. Current practice and future directions in the prevention and acute management of migraine. Lancet Neurol, 2010, 9(3): 285-298.
6.	Scher AI, Stewart WF, Lipton RB. Caffeine as a risk factor for chronic daily headache: a population-based study. Neurology, 2004, 63(11): 2022-2027.
7.	Silberstein SD, McCrory DC. Ergotamine and dihydroergotamine: history, pharmacology, and efficacy. Headache, 2003, 43(2): 144-166.
8.	Dodick D, Lipton RB, Martin V, et al. Consensus statement: cardiovascular safety profile of triptans (5-HT1B/1D agonists) in the acute treatment of migraine. Headache, 2004, 44(5): 414-425.
9.	Endres HG, Diener HC, Molsberger A. Role of acupuncture in the treatment of migraine. Expert Rev OF Neurotherapeutics, 2007, 7(9): 1121-1134.
10.	张琰, 刘慧林, 王麟鹏. 针刺预防性治疗偏头痛的文献质量评价. 中国循证医学杂志, 2008, 8(6): 461-465.
11.	Headache classification committee of the International Headache Society. Classification and diagnostic criteria for headache disorders, cranial neuralgias and facial pain. Cephalalgia: an international journal of headache, 1988, 8(suppl7): 1-96.
12.	Headache classification subcommittee of the International Headache Society. The international classification of headache disorders : 2nd Edition. Cephalalgia: an international journal of headache, 2004, 24(Suppl1): 9-160.
13.	Higgins JPT, Green S. Cochrane Handbook for Systematic Reviews of Interventions 4.2.6. The Cochrane Collaboration, 2006: 186-187.
14.	Landis JR, Koch GG. The measurement of observer agreement for categorical data. Biometrics, 1977, 33 (1): 159-174.
15.	Juni P, Altman DG, Egger M. Assessing the quality of controlled clinical trials. BMJ, 2001, 323(7303): 42-46.
16.	Jadad AR, Moore RA, Carroll D, et al. Assessing the quality of reports of randomized clinical trials: is blinding necessary? Control Clin Trials, 1996, 17(1): 1-12.
17.	Melchart D, Thormaehlen J, HAGER S, et al. Acupuncture versus placebo versus sumatriptan for early treatment of migraine attacks: a randomized controlled trial. Journal of Internal Medicine, 2003, 253: 181–188.
18.	Li Y, Liang FR, Yang XG, et al. Acupuncture for Treating Acute Attacks of Migraine: A Randomized Controlled Trial. Headache, 2009, 49(6): 805-816.
19.	张舒雁, 马泽云, 金国利. 邻点透刺加缠针震颤法治疗瘀血型偏头痛急性发作疗效观察. 中华中医药学刊, 2007, 25(2): 401-403.
20.	邓伟哲, 杨志欣. 深刺风池穴为主治疗偏头痛临床观察. 中国针灸, 2002, 22(10): 661-662.
21.	古英, 路瑜. 透刺为主治疗偏头痛的临床观察. 上海针灸杂志, 2008, 27(5): 24-25.
22.	刘波, 邱丽敏. 针刺“头四关穴”治疗偏头痛的临床研究. 辽宁中医杂志, 2006, 33(11): 1484-1485.
23.	张月成, 宋丽华. 针刺耳门与西药对照治疗偏头痛疗效观察. 中国针灸, 2002, 22(3): 159-160.
24.	孔庆爱, 高兵兵, 孟庆刚. 针刺疗法治疗偏头痛98例分析. 中医药学刊, 2003, 21(12): 2164-2166.
25.	李冬梅, 贾宝辉. 针刺治疗肝阳上亢型偏头痛的临床研究. 辽宁中医杂志, 2009, 36(9): 1579-1581.
26.	宁侠, 张文. 针刺治疗偏头痛即刻疗效的临床观察. 中国针灸, 2004: 11-12.
27.	张敏尚, 王秋景, 王山. 针刺治疗偏头痛3O例疗效观察. 四川中医, 2005, 23(1): 91-92.
28.	周建伟, 李季, 李宁, 等. 电针太阳穴治疗偏头痛肝阳上亢证即时镇痛效应研究. 中国针灸, 2007, 27(3): 159-163.
29.	陈宏伟, 杨国荣, 唐永春. 电针治疗偏头痛疗效观察. 上海针灸志, 2009, 28(6): 353-354.
30.	韩励兵. 偏头痛的针刺治疗回顾. 中国针灸, 2005, 增刊: 18-19.
31.	王斌. 项丛刺合围针治疗偏头痛. 上海针灸杂志, 2004, 23(4): 14-15.
32.	李志宏, 贺莉萍, 王灵, 等. 针刺手少阳经经穴为主治疗偏头痛32例临床观察. 湖南中医杂志, 2009, 25(2): 11-12.
33.	黎俐, 哈依尼. 针刺四关穴治疗偏头痛36例. 中国医学杂志, 2008, 6(9): 9-10.
34.	李丽霞, 王国明, 宋永强, 等. 针刺治疗偏头痛80例. 中国民间法, 2006, 14(5): 20-21.
35.	谢菊英, 刘伍立. 针刺治疗偏头痛及其对自主神经系统功能的影响. 中国针灸, 2003, 23(2): 77-79.
36.	谢菊英, 贺莉萍, 李志宏, 等. 针刺足厥阴经经穴治疗偏头痛及对颅内血流动力学的影响. 湘南学院学报(医学版), 2008, 10(4): 24-27.
37.	谢菊英, 贺莉萍, 李志宏, 等. 针刺足少阳经经穴为主治疗偏头痛31例临床观察. 中医药导报, 2009, 15(4): 60-61.
38.	老锦雄, 赖新生. 透穴为主治疗无先兆偏头痛的临床疗效观察. 中国针灸, 2002, 22(7): 448-450.
39.	周丽莎. 遵循标本根结理论针刺治疗偏头痛. 湖北中医杂志, 2003, 25(3): 44-45.
40.	国家中医药管理局. 中医病症诊断疗效标准. 南京大学出版社, 1994: 22-23.
41.	国家中医药管理局全国脑病急症协作组. 头风诊断与疗效评定标准. 山东中医药大学学报, 1993, 16(3): 69.
42.	中华人民共和国卫生部. 中药(新药)临床研究指导原则, 1995: 119-202.
43.	孙怡, 杨任民. 实用中西医结合神经病学. 人民卫生出版社, 1999: 418-420, 426-427.
44.	孙增华, 杨玉金. 偏头痛诊断、疗效评定标准. 中风与神经病杂志, 1995, 12(2): 110.
45.	Sackett DL, Haynes RB, Guyatt GH, et al. Clinical epidemiology, a basic science for clinical medicine: 2nd ed. Boston : Little Brown Co Inc, 1991: 192-223.
46.	Altman DG, Schulz KF, Moher D, et al. The Revised CONSORT Statement for Reporting Randomized Trials: Explanation and Elaboration. Ann Intern Med, 2001, 134: 663-694.
47.	Diener HC. Migraine: is acupuncture clinically viable for treating acute migraine? Nat Rev Neurol, 2009, 5(9): 469-470.
48.	Torgerson DJ, Roberts C. Randomisation methods: concealment. BMJ, 1999, 319(7206): 375 -376.
49.	Schulz KF, Chalmers I, Hayes RJ, et al. Empirical evidence of bias: dimensions of methodological quality associated with estimates of effects in controlled trials. JAMA, 1995, 273(5): 408-412.
50.	Eversa S, A´fra J, Frese A, et al. EFNS guideline on the drug treatment of migraine-revised report of an EFNS task force. European Journal of Neurology, 2009, 16(9): 968-981.
51.	MacPherson H, White A, Cummings M, et al. Standards for reporting interventions in controlled trials of acupuncture: the STRICTA recommendations. Complement Ther Med, 2001, 9(4): 246-249.
52.	International Headache Society Clinical Trials Subcommittee. Guidelines for controlled trials of drugs in migraine: second edition. Cephalalgia, 2000, 20: 765-786.
53.	Suthisisang CC, Poolsup N, Suksomboon N, et al. Meta-analysis of the efficacy and safety of naproxen sodium in the acute treatment of migraine. Headache, 2010, 50(5): 808-818.
54.	Chen LC, Ashcroft DM. Meta-analysis of the efficacy and safety of zolmitriptan in the acute treatment of migraine. Headache, 2008, 48(2): 236-247.
55.	Lipton RB, Dodick DW, Silberstein SD, et al. Single-pulse transcranial magnetic stimulation for acute treatment of migraine with aura: a randomised, double-blind, parallel-group, sham-controlled trial. Lancet Neurol, 2010, 9(4): 373-380.
56.	Tullo V, Allais G, Ferrari MD, et al. Frovatriptan versus zolmitriptan for the acute treatment of migraine: a double-blind, randomized, multicenter, Italian study. Neurol Sci, 2010, 31 Suppl 1: S51-S54.
57.	Spierings EL, Keywood C. Rapid responders to frovatriptan in acute migraine treatment: results from a long-term, open-label study. Pain Med, 2009, 10(4): 633-638.

1. 郭述苏. 中国偏头痛流行病学调查. 临床神经病学杂志, 1991, 4(2): 65.
2. Lipton RB, Bigal ME, Diamond M, et al. Migraine prevalence, disease burden, and the need for preventive therapy. Neurology, 2007, 68(5): 343-349.
3. Badia X, Magaz S, Gutierrez L, et al. The burden of migraine in Spain: beyond direct costs. Pharmacoeconomics, 2004, 22(9): 591-603.
4. Wang SJ, Chung CS, Chankrachang S, et al. Migraine disability awareness campaign in Asia: migraine assessment for prophylaxis. Headache, 2008, 48(9): 1356-1365.
5. Goadsby PJ, Sprenger T. Current practice and future directions in the prevention and acute management of migraine. Lancet Neurol, 2010, 9(3): 285-298.
6. Scher AI, Stewart WF, Lipton RB. Caffeine as a risk factor for chronic daily headache: a population-based study. Neurology, 2004, 63(11): 2022-2027.
7. Silberstein SD, McCrory DC. Ergotamine and dihydroergotamine: history, pharmacology, and efficacy. Headache, 2003, 43(2): 144-166.
8. Dodick D, Lipton RB, Martin V, et al. Consensus statement: cardiovascular safety profile of triptans (5-HT1B/1D agonists) in the acute treatment of migraine. Headache, 2004, 44(5): 414-425.
9. Endres HG, Diener HC, Molsberger A. Role of acupuncture in the treatment of migraine. Expert Rev OF Neurotherapeutics, 2007, 7(9): 1121-1134.
10. 张琰, 刘慧林, 王麟鹏. 针刺预防性治疗偏头痛的文献质量评价. 中国循证医学杂志, 2008, 8(6): 461-465.
11. Headache classification committee of the International Headache Society. Classification and diagnostic criteria for headache disorders, cranial neuralgias and facial pain. Cephalalgia: an international journal of headache, 1988, 8(suppl7): 1-96.
12. Headache classification subcommittee of the International Headache Society. The international classification of headache disorders : 2nd Edition. Cephalalgia: an international journal of headache, 2004, 24(Suppl1): 9-160.
13. Higgins JPT, Green S. Cochrane Handbook for Systematic Reviews of Interventions 4.2.6. The Cochrane Collaboration, 2006: 186-187.
14. Landis JR, Koch GG. The measurement of observer agreement for categorical data. Biometrics, 1977, 33 (1): 159-174.
15. Juni P, Altman DG, Egger M. Assessing the quality of controlled clinical trials. BMJ, 2001, 323(7303): 42-46.
16. Jadad AR, Moore RA, Carroll D, et al. Assessing the quality of reports of randomized clinical trials: is blinding necessary? Control Clin Trials, 1996, 17(1): 1-12.
17. Melchart D, Thormaehlen J, HAGER S, et al. Acupuncture versus placebo versus sumatriptan for early treatment of migraine attacks: a randomized controlled trial. Journal of Internal Medicine, 2003, 253: 181–188.
18. Li Y, Liang FR, Yang XG, et al. Acupuncture for Treating Acute Attacks of Migraine: A Randomized Controlled Trial. Headache, 2009, 49(6): 805-816.
19. 张舒雁, 马泽云, 金国利. 邻点透刺加缠针震颤法治疗瘀血型偏头痛急性发作疗效观察. 中华中医药学刊, 2007, 25(2): 401-403.
20. 邓伟哲, 杨志欣. 深刺风池穴为主治疗偏头痛临床观察. 中国针灸, 2002, 22(10): 661-662.
21. 古英, 路瑜. 透刺为主治疗偏头痛的临床观察. 上海针灸杂志, 2008, 27(5): 24-25.
22. 刘波, 邱丽敏. 针刺“头四关穴”治疗偏头痛的临床研究. 辽宁中医杂志, 2006, 33(11): 1484-1485.
23. 张月成, 宋丽华. 针刺耳门与西药对照治疗偏头痛疗效观察. 中国针灸, 2002, 22(3): 159-160.
24. 孔庆爱, 高兵兵, 孟庆刚. 针刺疗法治疗偏头痛98例分析. 中医药学刊, 2003, 21(12): 2164-2166.
25. 李冬梅, 贾宝辉. 针刺治疗肝阳上亢型偏头痛的临床研究. 辽宁中医杂志, 2009, 36(9): 1579-1581.
26. 宁侠, 张文. 针刺治疗偏头痛即刻疗效的临床观察. 中国针灸, 2004: 11-12.
27. 张敏尚, 王秋景, 王山. 针刺治疗偏头痛3O例疗效观察. 四川中医, 2005, 23(1): 91-92.
28. 周建伟, 李季, 李宁, 等. 电针太阳穴治疗偏头痛肝阳上亢证即时镇痛效应研究. 中国针灸, 2007, 27(3): 159-163.
29. 陈宏伟, 杨国荣, 唐永春. 电针治疗偏头痛疗效观察. 上海针灸志, 2009, 28(6): 353-354.
30. 韩励兵. 偏头痛的针刺治疗回顾. 中国针灸, 2005, 增刊: 18-19.
31. 王斌. 项丛刺合围针治疗偏头痛. 上海针灸杂志, 2004, 23(4): 14-15.
32. 李志宏, 贺莉萍, 王灵, 等. 针刺手少阳经经穴为主治疗偏头痛32例临床观察. 湖南中医杂志, 2009, 25(2): 11-12.
33. 黎俐, 哈依尼. 针刺四关穴治疗偏头痛36例. 中国医学杂志, 2008, 6(9): 9-10.
34. 李丽霞, 王国明, 宋永强, 等. 针刺治疗偏头痛80例. 中国民间法, 2006, 14(5): 20-21.
35. 谢菊英, 刘伍立. 针刺治疗偏头痛及其对自主神经系统功能的影响. 中国针灸, 2003, 23(2): 77-79.
36. 谢菊英, 贺莉萍, 李志宏, 等. 针刺足厥阴经经穴治疗偏头痛及对颅内血流动力学的影响. 湘南学院学报(医学版), 2008, 10(4): 24-27.
37. 谢菊英, 贺莉萍, 李志宏, 等. 针刺足少阳经经穴为主治疗偏头痛31例临床观察. 中医药导报, 2009, 15(4): 60-61.
38. 老锦雄, 赖新生. 透穴为主治疗无先兆偏头痛的临床疗效观察. 中国针灸, 2002, 22(7): 448-450.
39. 周丽莎. 遵循标本根结理论针刺治疗偏头痛. 湖北中医杂志, 2003, 25(3): 44-45.
40. 国家中医药管理局. 中医病症诊断疗效标准. 南京大学出版社, 1994: 22-23.
41. 国家中医药管理局全国脑病急症协作组. 头风诊断与疗效评定标准. 山东中医药大学学报, 1993, 16(3): 69.
42. 中华人民共和国卫生部. 中药(新药)临床研究指导原则, 1995: 119-202.
43. 孙怡, 杨任民. 实用中西医结合神经病学. 人民卫生出版社, 1999: 418-420, 426-427.
44. 孙增华, 杨玉金. 偏头痛诊断、疗效评定标准. 中风与神经病杂志, 1995, 12(2): 110.
45. Sackett DL, Haynes RB, Guyatt GH, et al. Clinical epidemiology, a basic science for clinical medicine: 2nd ed. Boston : Little Brown Co Inc, 1991: 192-223.
46. Altman DG, Schulz KF, Moher D, et al. The Revised CONSORT Statement for Reporting Randomized Trials: Explanation and Elaboration. Ann Intern Med, 2001, 134: 663-694.
47. Diener HC. Migraine: is acupuncture clinically viable for treating acute migraine? Nat Rev Neurol, 2009, 5(9): 469-470.
48. Torgerson DJ, Roberts C. Randomisation methods: concealment. BMJ, 1999, 319(7206): 375 -376.
49. Schulz KF, Chalmers I, Hayes RJ, et al. Empirical evidence of bias: dimensions of methodological quality associated with estimates of effects in controlled trials. JAMA, 1995, 273(5): 408-412.
50. Eversa S, A´fra J, Frese A, et al. EFNS guideline on the drug treatment of migraine-revised report of an EFNS task force. European Journal of Neurology, 2009, 16(9): 968-981.
51. MacPherson H, White A, Cummings M, et al. Standards for reporting interventions in controlled trials of acupuncture: the STRICTA recommendations. Complement Ther Med, 2001, 9(4): 246-249.
52. International Headache Society Clinical Trials Subcommittee. Guidelines for controlled trials of drugs in migraine: second edition. Cephalalgia, 2000, 20: 765-786.
53. Suthisisang CC, Poolsup N, Suksomboon N, et al. Meta-analysis of the efficacy and safety of naproxen sodium in the acute treatment of migraine. Headache, 2010, 50(5): 808-818.
54. Chen LC, Ashcroft DM. Meta-analysis of the efficacy and safety of zolmitriptan in the acute treatment of migraine. Headache, 2008, 48(2): 236-247.
55. Lipton RB, Dodick DW, Silberstein SD, et al. Single-pulse transcranial magnetic stimulation for acute treatment of migraine with aura: a randomised, double-blind, parallel-group, sham-controlled trial. Lancet Neurol, 2010, 9(4): 373-380.
56. Tullo V, Allais G, Ferrari MD, et al. Frovatriptan versus zolmitriptan for the acute treatment of migraine: a double-blind, randomized, multicenter, Italian study. Neurol Sci, 2010, 31 Suppl 1: S51-S54.
57. Spierings EL, Keywood C. Rapid responders to frovatriptan in acute migraine treatment: results from a long-term, open-label study. Pain Med, 2009, 10(4): 633-638.

Previous Article
Evidence-Based Treatment Practice for A Hepatitis B Related Nephritis Patient with Renal Failure

Chinese Journal of Evidence-Based Medicine

Reports Quality Evaluation on Acupuncture for Treating Acute Attacks of Migraine

Abstract Full text Figures/Tables Video References Cited by

Previous Article

Format

Content